Friedreich Ataxia Latest Advances

Pharmacotherapy of neuromuscular diseases : what's new in 2025

Journal: Revue medicale suisse

Published: January 16, 2026

Neuropathology of Friedreich ataxia and its links to metabolic pathways.

Journal: Neurodegenerative disease management

Published: December 25, 2025

The Impact of Calcitriol on Frataxin Levels in Friedreich's Ataxia Patients: Insights and Future Directions.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: December 12, 2025

Enhancing the Objective Assessment of Friedreich Ataxia Severity: A Multiview IMU-Based Approach.

Journal: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference

Published: December 03, 2025

Reliable Objective Assessment of Friedreich Ataxia Through Isolation Forest-Based Anomaly Detection.

Journal: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference

Published: December 03, 2025

Objective Assessment of Friedreich Ataxia in Children: Accounting for Developmental Deficits.

Journal: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference

Published: December 03, 2025

A case of Friedreich Ataxia and left ventricular hypertrophy induced by FXN gene mutation

Journal: Zhonghua xin xue guan bing za zhi

Published: November 25, 2025

Polyphenol-Enriched Fraction from Chestnut Shells as a Source of Bioactive Compounds for Friedreich Ataxia.

Journal: Molecules (Basel, Switzerland)

Published: October 28, 2025

Neuropsychiatric Challenges of Friedreich Ataxia in a Patient Residing in a Long-Term Care Facility.

Journal: The primary care companion for CNS disorders

Published: October 27, 2025

Integration of Evolutionary Analysis With RFdiffusion for De Novo Design of Aggregation-Resistant Frataxin.

Journal: Proteins

Published: October 19, 2025

Real-world evidence supporting orphan drugs approvals for rare neuromuscular disorders in the European Union and the United States: Review of public assessment reports (2015-2025).

Journal: Current opinion in pharmacology

Published: October 08, 2025

Author Correction: HMGB2-induced calreticulin translocation required for immunogenic cell death and ferroptosis of cancer cells are controlled by the nuclear exporter XPO1.

Journal: Communications biology

Published: October 04, 2025